Sunil Krishnan, MD
Vivian L. Smith Department of Neurosurgery
McGovern Medical School, UTHealth Houston
Dr. Sunil Krishnan is a board-certified radiation oncologist with clinical interests in gastrointestinal cancers.
He was a gastrointestinal radiation oncology faculty member at The University of Texas MD Anderson Cancer Center for more than 15 years and was the director of the Center for Radiation Oncology Research there. He joins McGovern Medical School and UTHealth Houston Neurosciences from Mayo Clinic in Jacksonville, Florida, where he was a professor with dual appointments in the radiation oncology and cancer biology departments and held the Florida Department of Health Cancer Research Endowed Chair.
In the clinic, Dr. Krishnan treats patients with hepatobiliary, pancreatic, and rectal tumors. His clinical research has helped define the role of radiation therapy in the management of these cancers and identified predictors of response to treatment. His laboratory research focuses on devising new strategies to sensitize tumors to radiation therapy and protect normal tissues from radiation injury using nanoparticles, chemotherapeutics, biologics, and botanicals. A major thrust of the laboratory has been to study nanotechnology application in cancer imaging and therapy. His laboratory research has been continuously funded by peer-reviewed extramural grants for over 15 years, the majority of these being from the National Institutes of Health.
Dr. Krishnan is a fellow of the American College of Physicians, the American Society for Radiation Oncology, and the American Institute for Medical and Biological Engineers. He is an active member of the American Society of Clinical Oncology and the American Society for Radiation Oncology, and has served on numerous committees for both organizations. He has served as co chair of the GI Translational Research Committee of the Radiation Therapy Oncology Group/NRG Oncology, chair of the gastrointestinal scientific program committee and education committee of the American Society for Radiation Oncology, and a consultant for liver cancers and advisor for rectal cancers at the International Atomic Energy Agency.
In Houston, he served as a member of the NASA Research and Clinical Advisory Panel. He serves on the editorial boards of PLoS One, Frontiers in Oncology, and Journal of Gastrointestinal Oncology, among many others, and is the editor-in-chief of Cancer Nanotechnology.
Collaboration with Referring Physicians
Physicians at UTHealth Houston Neurosciences engage referring physicians in the care of their patients, keeping them informed throughout the evaluation and treatment process. After treatment, referring physicians receive a summary and a plan for follow-up. We encourage continued communication about each patient.